Evogene Ltd. (EVGN) at a glance

Evogene Ltd. (EVGN) is a micro-cap Healthcare company. It trades at $0.39, with a P/E of 0.3, a -6.3% profit margin and revenue decline of 86.3%. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Value (89/100) and its weakest is Growth (11/100). Its volatility is roughly in line with the market.

Price

$0.39

Market cap

$6.1M

P/E ratio

0.3

Dividend yield

None

Beta

0.74

52-week range

$0.38 to $1.50